Granier et al. investigated the expression of PD-1 and TIM-3 on CD8+ T-cells and found that co-expression correlated with aggressive tumor phenotypes and poor survival outcomes across RCC tumor histologies [167]. The gene discussed is HAVCR2; the disease is renal cell carcinoma.